Breaking News

BREAKING: Trump Issues Drug Pricing Rules That Impact 340B; Says 340B Health Center Final Rule Is Coming

President Trump this afternoon announced two drug pricing rules with implications for the 340B program, and said his administration “in a few weeks” will finalize finalize regulations to require federally qualified health centers (FQHCs) to pass along 340B drug discounts on insulin and injectable epinephrine directly to patients. | Source: White House YouTube channel.

Trump Issues Drug Pricing Rules That Impact 340B; Says 340B Health Center Final Rule Is Coming

Medicare-participating 340B hospital outpatient departments will have to take part in the Trump administration’s “most favored nation” (MFN) payment test for Medicare Part B drugs, the U.S. Health and Human Services Department announced late today. 

“To the extent these entities receive payment under the model that is lower than their current Medicare payment, there may be fewer resources available for their 340B program activities,” the Centers for Medicare & Medicaid Services (CMS) acknowledged in an interim final rule posted for public inspection this afternoon. The rule takes effect Jan. 1, 2021. CMS is accepting public comments; the deadline is 5 p.m. on Jan. 26, 2021.

.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer